Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946916 | IM / LA |
Pt presents for further evaluation left shoulder discomfort after receiving her Hep B series vaccine on 04/09/2026. Pt admits she noticed some discomfort with moving her shoulder, specifically with abduction and extension. No radicular symptoms, paresthesias or weakness. No prior hx of a soft tissue issue.